NCT05519228View on ClinicalTrials.gov

PMCF Study on the Safety, Performance and Clinical Benefits Data of the ToggleLoc™ 2.9mm in the Elbow

CompletedOBSERVATIONAL
Enrollment

83

Participants

Timeline

Start Date

September 12, 2022

Primary Completion Date

September 27, 2023

Study Completion Date

February 20, 2024

Conditions
Epicondylitis of the ElbowBiceps Tendon Disorder
Interventions
DEVICE

ToggleLoc 2.9 mm Soft Tissue System

The ToggleLoc 2.9 mm Soft Tissue System consist of non-resorbable device intended to aid in arthroscopic and orthopaedic reconstructive procedures requiring soft tissue to bone fixation

Trial Locations (2)

22033

OrthoVirginia, Fairfax

28823

ASEPEYO Hospital, Madrid

Sponsors

Lead Sponsor

Zimmer Biomet
All Listed Sponsors
lead

Zimmer Biomet

INDUSTRY

NCT05519228 - PMCF Study on the Safety, Performance and Clinical Benefits Data of the ToggleLoc™ 2.9mm in the Elbow | Biotech Hunter | Biotech Hunter